Advertisement
Screener

The Procter & Gamble Company (PG) Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

The Procter & Gamble Company Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

The Procter & Gamble Company (PG) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$86.00 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-04.

Financial Statements › Cash Flow › Change in Cash

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04

  • The Procter & Gamble Company effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-09-30 was -$20.00M, a 117.24% decline year-over-year.
  • The Procter & Gamble Company effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-09-30 was $116.00M.
  • The Procter & Gamble Company effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-09-30 was -$156.00M.
  • The Procter & Gamble Company effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2022-09-30 was -$235.00M.
  • The Procter & Gamble Company effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2026 was -$86.00M, a 176.79% decline from fiscal 2025.
  • The Procter & Gamble Company effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $112.00M.
  • The Procter & Gamble Company effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$251.00M.
  • The Procter & Gamble Company effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$170.00M.
Period endEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 monthEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 monthEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 monthEffect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month
2026-06-30-$86.00M
10-K · filed 2026-08-04
2026-03-31-$94.00M
10-Q · filed 2026-04-24
2025-12-31-$21.00M
10-Q · filed 2026-01-23
2025-09-30-$20.00M
10-Q · filed 2025-10-24
2025-06-30$112.00M
10-K · filed 2026-08-04
2025-03-31-$22.00M
10-Q · filed 2026-04-24
2024-12-31-$144.00M
10-Q · filed 2026-01-23
2024-09-30$116.00M
10-Q · filed 2025-10-24
2024-06-30-$251.00M
10-K · filed 2026-08-04
2024-03-31-$168.00M
10-Q · filed 2025-04-24
2023-12-31-$49.00M
10-Q · filed 2025-01-22
2023-09-30-$156.00M
10-Q · filed 2024-10-18
2023-06-30-$170.00M
10-K · filed 2025-08-04
2023-03-31-$170.00M
10-Q · filed 2024-04-19
2022-12-31-$182.00M
10-Q · filed 2024-01-23
2022-09-30-$235.00M
10-Q · filed 2023-10-18
2022-06-30-$497.00M
10-K · filed 2024-08-05
2022-03-31-$312.00M
10-Q · filed 2023-04-21
2021-12-31-$256.00M
10-Q · filed 2023-01-19
2021-09-30-$127.00M
10-Q · filed 2022-10-19
2021-06-30$101.00M
10-K · filed 2023-08-04
2021-03-31$65.00M
10-Q · filed 2022-04-20
2020-12-31$146.00M
10-Q · filed 2022-01-19
2020-09-30$31.00M
10-Q · filed 2021-10-19
2020-06-30-$139.00M
10-K · filed 2022-08-05
2020-03-31-$179.00M
10-Q · filed 2021-04-20
2019-12-31-$9.00M
10-Q · filed 2021-01-20
2019-09-30-$65.00M
10-Q · filed 2020-10-20
2019-06-30-$88.00M
10-K · filed 2021-08-06
2019-03-31-$95.00M
10-Q · filed 2020-04-20
2018-12-31-$113.00M
10-Q · filed 2020-01-23
2018-06-30$19.00M
10-K/A · filed 2020-08-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
ECOLAB INC. (ECL)United States$77.183B36.58
CHURCH & DWIGHT CO INC /DE/ (CHD)United States$22.622B30.81
STEPAN CO (SCL)United States$1.451B-477.05
Longevity Health Holdings, Inc. (XAGE)United States$0.006B-0.09